SLC22A2 and Anxiety: OCT2 mutant and wild-type (WT) mice were tested in basal conditions, following chronic corticosterone administration and after 3 weeks fluoxetine treatment along with corticosterone, with a sequential battery of tests evaluating anhedonia, social withdrawal, anxiety and cognitive impairment (Fig. 1A).